Jessica Sachs Cogent Biosciences, Inc. (COGT) insider trading activity

COGT Quotes by TradingView

Jessica Sachs is Chief Medical Officer of Cogent Biosciences, Inc.. Currently has a direct ownership of 133,938 shares of COGT, which is worth approximately $4.49 Million. The most recent transaction as insider was on Dec 26, 2025, when has been sold 82,642 shares (Common Stock) at a price of $38.7 per share, resulting in proceeds of $3,198,245. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 134K
21433.44% 3M change
21433.44% 12M change
Total Value Held $4.49 Million

Jessica Sachs Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 26 2025
SELL
Open market or private sale
$3,198,245 $38.7 p/Share
82,642 Reduced 38.16%
133,938 Common Stock
Dec 17 2025
SELL
Payment of exercise price or tax liability
$6,103,546 $39.45 p/Share
154,716 Reduced 41.67%
216,580 Common Stock
Dec 17 2025
BUY
Grant, award, or other acquisition
-
370,000 Added 49.91%
371,296 Common Stock
Jun 30 2022
BUY
Grant, award, or other acquisition
$4,597 $7.39 p/Share
622 Added 50.0%
622 Common Stock
Dec 31 2021
BUY
Grant, award, or other acquisition
$4,597 $6.82 p/Share
674 Added 50.0%
674 Common Stock
JS

Jessica Sachs

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on COGT

Follow Cogent Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COGT shares.

Notify only if

Insider Trading

Get notified when an Cogent Biosciences, Inc. insider buys or sells COGT shares.

Notify only if

News

Receive news related to Cogent Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on COGT